Topotecan–Berzosertib Combination Shows Promise against Small Cell Lung Cancer

Topotecan–Berzosertib Combination Shows Promise against Small Cell Lung Cancer

SEMrush
Combining the chemotherapy drug topotecan and the investigational drug berzosertib shrank tumors in some patients with small cell lung cancer, results from an NCI-supported phase 1 clinical trial show. Two phase 2 trials of the combination are planned.
[automaticbacklinks]